U.S. RESEARCH ROUNDUP-Apollo, Booking Holdings, Portillos

Reuters11-06 15:01

Nov 6 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Apollo, Booking Holdings and Portillos, on Wednesday.

HIGHLIGHTS

* Apollo : JP Morgan raises target price to $161 from $143

* Aris Water Solutions Inc : JP Morgan cuts to neutral from overweight

* Booking Holdings Inc : Truist Securities raises target to $4,700 from $4,100

* Choice Hotels International Inc : Jefferies cuts to hold from buy

* Portillos Inc : Stifel cuts to hold from buy

Following is a summary of research actions on U.S. companies reported by Reuters on Wednesday. Stock entries are in alphabetical order.

* Adapthealth Corp : Canaccord Genuity cuts target price to $13 from $14

* Agco Corp : JP Morgan cuts target price to $105 from $117

* AIG : Jefferies cuts target price to $86 from $88

* Anaptysbio Inc : Leerink Partners cuts target price to $45 from $47

* Apellis Pharmaceuticals Inc : Piper Sandler cuts target price to $32 from $40

* Apellis Pharmaceuticals Inc : TD Cowen cuts target price to $60 from $95

* Apollo : JP Morgan raises target price to $161 from $143

* Arcellx Inc : Baird raises target price to $106 from $77

* Arcellx Inc : H.C. Wainwright raises target price to $95 from $80

* Aris Water Solutions Inc : JP Morgan cuts to neutral from overweight

* Aris Water Solutions Inc : JP Morgan raises target price to $22 from $19

* Aspen Technology Inc : Piper Sandler raises target price to $240 from $217

* Bioventus Inc : Canaccord Genuity raises target price to $15 from $12

* Booking Holdings Inc : Truist Securities raises target to $4,700 from $4,100

* Broadridge Financial Solutions Inc : D.A. Davidson raises target to $210 from $205

* Broadridge Financial Solutions Inc : JP Morgan raises target price to $231 from $225

* Broadridge Financial Solutions Inc : Raymond James raises target to $235 from $230

* Bruker Corp : JP Morgan cuts target price to $80 from $90

* Caretrust REIT Inc : Jefferies raises target price to $36 from $35

* Celanese Corp : JP Morgan cuts target price to $92 from $130

* Choice Hotels International Inc : Jefferies cuts to hold from buy

* Cummins : Jefferies raises target price to $410 from $385

* Cummins : JP Morgan raises target price to $355 from $340

* Exact Sciences Corp : BTIG cuts target price to $65 from $82

* Exact Sciences Corp : Canaccord Genuity cuts target price to $75 from $95

* Fis : Stephens raises target price to $100 from $98

* Freshpet Inc : Stephens raises target price to $180 from $160

* Gartner : Jefferies raises target price to $525 from $505

* Globalfoundries Inc : Susquehanna cuts target price to $48 from $50

* Globus Medical Inc : Canaccord Genuity raises target price to $85 from $79

* Globus Medical Inc : Jefferies raises target price to $100 from $85

* GXO Logistics Inc : TD Cowen raises target price to $83 from $82

* Highpeak Energy Inc : Gerdes Energy Research cuts target price by $1 to $11

* Inozyme pharma Inc : Jefferies cuts target price to $15 from $17

* Jeld-Wen Holding Inc : Barclays cuts target price to $10 from $13

* Leidos : JP Morgan raises target price to $205 from $185

* Lindblad Expeditions Holdings, Inc. : Craig-Hallum raises target to $16 from $12

* LTC Properties Inc : Jefferies raises target price to $35 from $33

* Lumen Technologies : TD Cowen cuts target price to $6 from $7

* Maplebear Inc : Oppenheimer raises target price to $55 from $48

* Masimo Corp : Jefferies raises target price to $145 from $125

* Masimo Corp : Piper Sandler raises target price to $180 from $165

* Meritage Homes Corp : JP Morgan raises target price to $220 from $210

* Microchip Technology : Jefferies cuts target price to $90 from $100

* Microchip Technology : JP Morgan cuts target price to $90 from $100

* Microchip Technology : Piper Sandler cuts target price to $85 from $100

* Multiplan Corp : Piper Sandler cuts target price to $10 from $40

* Myers Industries Inc : KeyBanc cuts to sector weight from overweight

* Omega Healthcare Investors Inc : Jefferies raises target price to $40 from $36

* Payoneer Global Inc : Needham raises target price to $14 from $10

* Portillos Inc : Piper Sandler raises target price to $15 from $13

* Portillos Inc : Stifel cuts to hold from buy

* Premier Inc : Canaccord Genuity raises target price to $21 from $19

* Qualys Inc : Canaccord Genuity raises target price to $170 from $160

* Qualys Inc : JP Morgan raises target price to $126 from $125

* Revolve Group Inc : Jefferies raises target price to $25 from $21

* Rhythm Pharmaceuticals Inc : Canaccord Genuity raises target to $80 from $77

* Sabra Health Care REIT Inc : Jefferies raises target price to $21 from $20

* Sotera Health Co : Jefferies raises target price to $18 from $16.5

* Targa Resources Corp : Raymond James raises target price to $200 from $185

* Tempus Ai Inc : JP Morgan raises target price to $50 from $47

* Timken Co : D.A. Davidson cuts target price to $99 from $103

* Timken Co : Jefferies cuts target price to $80 from $85

* Timken Co : KeyBanc cuts target price to $90 from $104

* Treace Medical Concepts Inc : Truist Securities raises target to $7 from $6

* Uber : D.A. Davidson raises target price to $84 from $82

* Ultragenyx Pharmaceutical Inc : Canaccord Genuity raises target to $121 from $109

* Verve Therapeutics Inc : Canaccord Genuity raises target price to $32 from $29

* Viper Energy Inc : Truist Securities raises target price to $64 from $57

* Xylem Inc : TD Cowen cuts target price to $125 from $138

* Zoetis Inc : Jefferies cuts target price to $200 from $210

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment